2024 Ai Summit Logo

Back to 2024 Agenda

Navigating the Reimbursement Landscape for AI/ML-Enabled Medical Device

November 14, 2024 @ 1:00 pm

-

2:00 pm

Moderator

Cindy Ipach, President & CEO, Compliance Insight

Speaker

Julie Nadeau, Sr. Reimbursement Strategist, NAMSA

This session provides a comprehensive overview of the reimbursement landscape for AI/ML-enabled medical devices. Participants will explore the unique challenges and opportunities in securing reimbursement for these innovative technologies. The course covers key topics such as regulatory pathways, coding strategies, payer perspectives, and evidence requirements. Attendees will learn about the current reimbursement environment, including Medicare, Medicaid, and private payer policies, and gain insights into how to effectively communicate the value of AI/ML-enabled devices to stakeholders. By the end of the course, participants will be equipped with the knowledge and tools necessary to develop a robust reimbursement strategy and navigate the evolving healthcare reimbursement ecosystem.

The AFDO/RAPS Healthcare Products Collaborative is a joint venture established in 2022 between the Association of Food and Drug Officials and the Regulatory Affairs Professionals Society. Learn more.

Newsletter

Stay in the know about upcoming events and breaking news from the collaborative.

Subscribe

ContACT Us

Have questions about our events, registration, CEUs, sponsorship, or something else?

Get in touch

© 2024 AFDO/RAPS Healthcare Products Collaborative